Vaginal misoprostol and intravenous oxytocin for success of termination in the second‐trimester intrauterine fetal demise: A randomized controlled clinical trial.
- Published in:
- Journal of Obstetrics & Gynaecology Research, 2022, v. 48, n. 4, p. 966, doi. 10.1111/jog.15180
- By:
- Publication type:
- Article